Alicia León‐Castillo

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

Alicia León‐Castillo, Stephanie M. de Boer, Melanie Powell et al. · Journal of Clinical Oncology · 2020 · 837 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Clinicopathological and molecular characterisation of ‘multiple‐classifier’ endometrial carcinomas

Alicia León‐Castillo, Ester Gilvazquez, Remi A. Nout et al. · The Journal of Pathology · 2019 · 402 citations · Full text

Medicine, Oncology, Pathology +17

Interpretation of somatic <i>POLE</i> mutations in endometrial carcinoma

Alicia León‐Castillo, Heidi Britton, Melissa K. McConechy et al. · The Journal of Pathology · 2019 · 392 citations · Full text

Medicine, Genetics, Oncology +17

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

Lisa Vermij, Jan J. Jobsen, Alicia León‐Castillo et al. · British Journal of Cancer · 2023 · 162 citations · Full text

Medicine, Gynecology, Oncology +15

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

Lisa Vermij, Alicia León‐Castillo, Naveena Singh et al. · Modern Pathology · 2022 · 161 citations · Full text

Medicine, Oncology, Pathology +17